{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:21:57Z","timestamp":1791184917440,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":4026,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.breast.2008.04.001","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T04:09:17Z","timestamp":1210824557000},"page":"436-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions"],"prefix":"10.1016","volume":"17","author":[{"given":"Kelly","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Juraskova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2008.04.001_bib1","unstructured":"Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR); 2001."},{"issue":"9472","key":"10.1016\/j.breast.2008.04.001_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2008.04.001_bib3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1525-1497.2003.20724.x","article-title":"Meta-analysis of vascular and neoplastic events associated with tamoxifen","volume":"18","author":"Braithwaite","year":"2003","journal-title":"J Gen Intern Med"},{"issue":"9453","key":"10.1016\/j.breast.2008.04.001_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2008.04.001_bib5","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1056\/NEJMoa052258","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.breast.2008.04.001_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2008.04.001_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2\u20133 years' tamoxifen treatment (intergroup exemestane study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2008.04.001_bib8","doi-asserted-by":"crossref","unstructured":"Boccardo F. Switching to anastrozole (ANA) vs. continued tamoxifen (TAM) treatment of early breast cancer (EBC). Updated results of the Italian tamoxifen anastrozole (ITA) trial. In: Paper presented at: 41st annual meeting of the American Society of Clinical Oncology (ASCO). Orlando, United States; 2005.","DOI":"10.1200\/jco.2005.23.16_suppl.526"},{"key":"10.1016\/j.breast.2008.04.001_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine responsive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results of ABCSG trial 8 and the ARNO 95 trial","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.breast.2008.04.001_bib10","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomised trial of letrozole in postmenopausal women after 5 years of tamoxifen therapy for early stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2008.04.001_bib11","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomised trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA17","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2008.04.001_bib12","author":"National Breast Cancer Centre"},{"issue":"3","key":"10.1016\/j.breast.2008.04.001_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3747\/co.2007.117","article-title":"The National Cancer Institute of Canada Trials Group MAP.3 trial: an international breast cancer prevention trial","volume":"14","author":"Richardson","year":"2007","journal-title":"Curr Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib14","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1999.17.9.2659","article-title":"Health-related quality of life and tamoxifen in breast cancer prevention: a report from the national surgical adjuvant breast and bowel project P-1 study","volume":"17","author":"Day","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib15","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO.1999.17.5.1488","article-title":"Effect of tamoxifen on sexual functioning in patients with breast cancer","volume":"17","author":"Mortimer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib16","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.bjc.6600294","article-title":"Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy","volume":"86","author":"Mourits","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2008.04.001_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(06)70767-7","article-title":"Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early stage breast cancer: long term safety analysis of the ATAC trial","volume":"7","author":"ATAC Trialists' Group","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib18","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2005.03.3654","article-title":"Quality of life in the intergroup exemestane study: a randomised trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer","volume":"24","author":"Fallowfield","year":"2006","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.breast.2008.04.001_bib20","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","article-title":"Assessment of quality of life in MA 17: a randomised, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women","volume":"23","author":"Whelan","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib21","doi-asserted-by":"crossref","first-page":"6s","DOI":"10.1200\/jco.2004.22.90140.516","article-title":"A planned comparison of menopausal symptoms during the first year in 1000 patients receiving either exemestane of tamoxifen in a double blind adjuvant hormonal study","volume":"22","author":"Asmar","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00001813-200409000-00003","article-title":"Acute effects of tamoxifen and third generation aromatase inhibitors on menopausal symptoms of breast cancer patients","volume":"15","author":"Morales","year":"2004","journal-title":"Anticancer Drugs"},{"issue":"10","key":"10.1016\/j.breast.2008.04.001_bib23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1503\/cmaj.1020174","article-title":"Women's sexual dysfunction: revised and expanded definitions","volume":"172","author":"Basson","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.breast.2008.04.001_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00345-002-0268-1","article-title":"The use of validated questionnaires to assess female sexual dysfunction","volume":"20","author":"Jones","year":"2002","journal-title":"World J Urol"},{"key":"10.1016\/j.breast.2008.04.001_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00435972","article-title":"The sexual activity questionnaire: a measure of women's sexual functioning","volume":"5","author":"Thirlaway","year":"1996","journal-title":"Qual Life Res"},{"issue":"9483","key":"10.1016\/j.breast.2008.04.001_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(05)66519-1","article-title":"Treatment of menopausal symptoms: what shall we do now?","volume":"366","author":"Hickey","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2008.04.001_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer \u2013 is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2008.04.001_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomised trial","volume":"97","author":"Von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2008.04.001_bib29","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.1999.17.5.1482","article-title":"Estrogen replacement therapy after localised breast cancer: clinical outcome of 319 women followed prospectively","volume":"17","author":"Vassilopoulou-Sellin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2008.04.001_bib31","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archinte.166.14.1453","article-title":"Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review","volume":"166","author":"Nedrow","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.breast.2008.04.001_bib32","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"S2","key":"10.1016\/j.breast.2008.04.001_bib33","first-page":"S778","article-title":"OVER (olive oil, vaginal exercises and replens) come: an intervention study to improve sexual function in women with breast cancer","volume":"15","author":"Mok","year":"2006","journal-title":"Psychooncology"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977608001136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977608001136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:24:37Z","timestamp":1760775877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977608001136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0960977608001136"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2008.04.001","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2008.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}